ERD

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabo...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Should we undertake surveillance for HCC in patients with NAFLD?

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort�...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Editorial: collagen proportionate area as a prognostic indicator in NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Detailed dissemination plan

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Final reports summarising recruitment into the EPoS database, biobanked samples availability, and longitudinal outcome s...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with no...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reapprais...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: A...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Relationship Among Fatty Liver, Specific and Multiple‐Site Atherosclerosis, and 10‐Year Framingham Score

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling reality

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Periodic Reporting for period 3 - EPoS (Elucidating Pathways of Steatohepatitis)

Project: EPoS

Updated at: 28-07-2022

Show more information

Project acronym EPoS

Resources

Selected filters:

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD

Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabo...

Should we undertake surveillance for HCC in patients with NAFLD?

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort�...

Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

Editorial: collagen proportionate area as a prognostic indicator in NAFLD

Detailed dissemination plan

Final reports summarising recruitment into the EPoS database, biobanked samples availability, and longitudinal outcome s...

Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with no...

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance

Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and...

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reapprais...

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism

Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling

Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD

Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: A...

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation

Relationship Among Fatty Liver, Specific and Multiple‐Site Atherosclerosis, and 10‐Year Framingham Score

Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling reality

Periodic Reporting for period 3 - EPoS (Elucidating Pathways of Steatohepatitis)